Retinoic acid suppression of squamous differentiation in human head-and-neck squamous carcinoma cells.
Retinoids (vitamin A analogues) inhibit the squamous differentiation of normal and malignant epithelial cells. This study investigated the ability of the head-and-neck squamous-cell carcinoma (HNSCC) cell line 1483 to undergo squamous differentiation in the absence and presence of beta-all-trans retinoic acid (RA). The growth of these cells in culture is accompanied by an increase in keratinocyte transglutaminase, involucrin and keratin KI, 3 established markers of squamous cell differentiation. Higher levels of these differentiation markers were detected in cells cultured in delipidized serum (DLS), from which endogenous retinoids have been extracted, than in cells cultured in fetal bovine serum (FBS), which contains retinoids. Treatment with I microM RA decreased the levels of the various differentiation markers in cells cultured in either FBS or DLS as revealed by immunofluorescent labelling of permeabilized cells and by immunoblotting of cell extracts using specific monoclonal or polyclonal antibodies. The cells' ability to cross-link proteins to form envelopes under the plasma membrane was stimulated in the presence of calcium ionophore but inhibited by RA. These results indicate that the malignant 1,483 HNSCC cells recapitulate the main characteristics of normal squamous-cell differentiation in culture and that RA suppresses this differentiation as it does in normal keratinizing epithelial cells.
Poddar
S
S
Department of Tumor Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Hong
W K
WK
Thacher
S M
SM
Lotan
R
R
D002118:Calcium / Q000378:metabolism; D002294:Carcinoma, Squamous Cell / Q000378:metabolism / Q000473:pathology*; D002454:Cell Differentiation / Q000187:drug effects; D005455:Fluorescent Antibody Technique; D006258:Head and Neck Neoplasms / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D015151:Immunoblotting; D007476:Ionophores / Q000494:pharmacology; D015603:Keratinocytes / Q000187:drug effects* / Q000201:enzymology / Q000648:ultrastructure; D007633:Keratins / Q000187:drug effects; D009363:Neoplasm Proteins / Q000187:drug effects; D011498:Protein Precursors / Q000187:drug effects; D012176:Retinoids / Q000097:blood; D011503:Transglutaminases / Q000187:drug effects; D014212:Tretinoin / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
D007476:Ionophores; D009363:Neoplasm Proteins; D011498:Protein Precursors; D012176:Retinoids; D014212:Tretinoin; C032253:involucrin; D007633:Keratins; D011503:Transglutaminases; D002118:Calcium